| 17.07 14:13 | MÄRKTE USA/Deutliche Abgaben nach jüngster Rekordjagd |
| 17.07 14:06 | dpa-AFX: Johnson & Johnson senkt wegen Kosten für Zukäufe Gewinnprognose |
| 17.07 14:06 | Johnson & Johnson senkt wegen Kosten für Zukäufe Gewinnprognose |
| 17.07 14:01 | dpa-AFX: Johnson & Johnson senkt wegen Kosten für Zukäufe Gewinnprognose |
| 17.07 13:47 | dpa-AFX: Johnson & Johnson Q2 Adj. EPS Beats View, Cuts FY24 Earnings Forecast |
| 17.07 13:10 | dpa-AFX: *JOHNSON & JOHNSON VORBÖRSLICH -1,3% NACH GESENKTEM GEWINNZIEL JE AKTIE 2024 |
| 17.07 12:43 | dpa-AFX: *JOHNSON & JOHNSON DECLARES Q3 CASH DIVIDEND OF $1.24/SHR, PAYABLE SEPT. 10, RECORD AUG. 27 |
| 17.07 12:34 | dpa-AFX: *JOHNSON & JOHNSON LOWERS FY EPS VIEW TO $9.97 - $10.07; LIFTS FY REVENUE VIEW $89.2 - $89.6 BLN |
| 17.07 12:33 | dpa-AFX: *JOHNSON & JOHNSON (JNJ) DECLARES $ 1.24 DIVIDEND FOR Q3 24, RECORD DATE 8/27/2024 |
| 17.07 12:32 | dpa-AFX: *JOHNSON & JOHNSON NOW SEES FY ADJ OPERATIONAL EPS PRE-M&A $10.73; ADJ OPERATIONAL EPS $10.05 |
| 17.07 12:30 | dpa-AFX: *JOHNSON & JOHNSON Q2 ADJ OPERATIONAL SALES UP 6.5%; ADJ OPERATIONAL SALES, EXCL COVID-19 VACCINE, UP 7.1% |
| 17.07 12:29 | dpa-AFX: *JOHNSON & JOHNSON Q2 SALES UP 4.3% TO $22.4 BLN WITH OPERATIONAL GROWTH OF 6.6% |
| 17.07 12:28 | dpa-AFX: Johnson & Johnson Q2 Profit Decreases, But Beats Estimates |
| 17.07 12:23 | dpa-AFX: *JOHNSON & JOHNSON Q2 EPS $1.93 VS. $2.05 LAST YEAR |
| 17.07 12:04 | dpa-AFX: Johnson & Johnson Q2 24 Earnings Conference Call At 8:30 AM ET |
| 17.07 11:18 | dpa-AFX: ROUNDUP/Gericht zu Covid-Impfstoff: EU-Kommission gab zu wenig Infos |
| 17.07 11:18 | ROUNDUP/Gericht zu Covid-Impfstoff: EU-Kommission gab zu wenig Infos |
| 17.07 11:13 | dpa-AFX: ROUNDUP/Gericht zu Covid-Impfstoff: EU-Kommission gab zu wenig Infos |
| 17.07 05:26 | dpa-AFX: ORIC Enters Into Clinical Trial Collaboration And Supply Agreements With Bayer and J&J; Stock Up |
| 03.07 14:10 | dpa-AFX: Johnson & Johnson Announces Health Canada NOC For RYBREVANT Combination |
|
|
